Choate's Life Sciences Insights

Follow Choate's Life Sciences Insights
Share on
Copy link to clipboard

A podcast series hosted by our intellectual property, litigation, and corporate attorneys covering trending topics at the intersection of science and law.

Choate LLP


    • Jun 12, 2023 LATEST EPISODE
    • infrequent NEW EPISODES
    • 14m AVG DURATION
    • 8 EPISODES


    Search for episodes from Choate's Life Sciences Insights with a specific topic:

    Latest episodes from Choate's Life Sciences Insights

    A Debrief of the Supreme Court’s Decision in Amgen v. Sanofi

    Play Episode Listen Later Jun 12, 2023 20:50


    In this episode of Choate's Life Sciences Insights Podcast Series, Sophie Wang, Stephanie Schonewald and Peter Flynn discuss the US Supreme Court's opinion in Amgen v. Sanofi, one of this term's most highly-watched cases for our clients concerning the law of enablement as it applies to patents directed to antibody therapeutics.

    PTAB Podcast: Recent USPTO Update on Fintiv Factors and Discretionary Denials

    Play Episode Listen Later Jul 11, 2022 18:27


    Steph Schonewald, Sophie Wang and Emily Miller discuss the recent memo issued by USPTO Director Vidal concerning the Fintiv factors and discretionary denials in AIA post-grant proceedings.

    Conducting Clinical Trials Part 5: Confidentiality Issues

    Play Episode Listen Later Dec 6, 2021 19:24


    In the fifth and final installment of Choate's Conducting Clinical Trials series, Julia Hesse and Danielle Pelot analyze confidentiality issues that can arise with clinical trial information and provide cautionary takeaways for when sponsors (life sciences companies) are planning and working with sites in structuring trials.  

    Conducting Clinical Trials Part 4: Financial Conflicts of Interest

    Play Episode Listen Later Nov 8, 2021 13:33


    In the fourth installment of Choate's Conducting Clinical Trials series, Mark McPherson and Greta Fails cover what financial conflicts of interest are in a clinical trials context, how federal funding agencies regulate them, and enforcement trends.

    Conducting Clinical Trials Part 3: Common Mistakes in Press Releases

    Play Episode Listen Later Oct 18, 2021 9:25


    In the third installment of Choate's Conducting Clinical Trials series, Diana Lloyd and Melissa Tearney discuss common mistakes made in clinical trial related press releases and how companies can avoid unnecessary government investigations and disastrous consequences caused by problematic press releases.

    Conducting Clinical Trials Part 2: Avoiding Mistaken Public Disclosures

    Play Episode Listen Later Sep 30, 2021 11:39


    In the second installment of Choate's Conducting Clinical Trials series, Christine Savage and Eric Marandett cover issues that can arise when there is premature or mistaken public disclosure of sensitive clinical trial information and discuss strategies companies can use to minimize the likelihood of encountering issues from inadvertently releasing information.

    Conducting Clinical Trials Part 1: When Should You File Your Patent Applications?

    Play Episode Listen Later Sep 13, 2021 14:56


    As the first installment of Choate's Conducting Clinical Trials series, Bryana McGillycuddy and John Rearick discuss a range of implications associated with the timing of filing, including the validity of the patent and the risk of inadvertent disclosure.

    Does the Amgen Case Raise the Bar for Enablement?

    Play Episode Listen Later May 17, 2021 10:25


    Eric Marandett and Rolando Medina review Amgen v. Sanofi and discuss strategies for how to successfully describe, claim, and assert antibody patents in the evolving legal landscape.

    Claim Choate's Life Sciences Insights

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel